Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CINOPSIS CT: Ioversol vs Iodixanol in Renal Impairment
NCT00793182Phase 4Terminated
- Sponsor
- Guerbet
- Start
- Jan 2009
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ioversol (2 arms), sponsored by Guerbet. Primary endpoint: Percentage of Patients With Contrast-induced Nephropathy. Started Jan 2009; status: terminated.
02
Drugs
ioversol
Beyond the preview
Go deeper on NCT00793182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00793182.